1. Home
  2. LMAT vs DAWN Comparison

LMAT vs DAWN Comparison

Compare LMAT & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$111.81

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.50

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMAT
DAWN
Founded
1983
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
LMAT
DAWN
Price
$111.81
$21.50
Analyst Decision
Buy
Buy
Analyst Count
5
8
Target Price
$105.80
$24.43
AVG Volume (30 Days)
143.7K
1.4M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
0.87%
N/A
EPS Growth
30.57
N/A
EPS
2.52
N/A
Revenue
$249,602,000.00
$158,182,000.00
Revenue This Year
$14.21
$55.03
Revenue Next Year
$8.88
$28.12
P/E Ratio
$45.48
N/A
Revenue Growth
13.53
20.60
52 Week Low
$78.01
$5.64
52 Week High
$118.01
$21.53

Technical Indicators

Market Signals
Indicator
LMAT
DAWN
Relative Strength Index (RSI) 52.51 80.29
Support Level $81.60 $10.30
Resistance Level $113.40 N/A
Average True Range (ATR) 2.88 0.03
MACD -0.49 -0.28
Stochastic Oscillator 21.35 90.91

Price Performance

Historical Comparison
LMAT
DAWN

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: